Strategic Research Sponsor of the American Bar Association's Section of International LawThe Queen's Award for Enterpise 2012

Yong Bai

Yong Bai
Office:
Room 3326 China World Tower 1
No 1 Jianguomenwai Dajie
100004
City:
Beijing
Country:
China
Tel:
+861065352286
Fax:
+861065059028

Biographies:

Who's Who Legal Competition: Lawyers

Bai Yong is counsel in Clifford Chance's antitrust practice in Mainland China. Before joining the firm, he worked for the Ministry of Commerce of the People's Republic of China (MOFCOM). He is a member of the firm's healthcare and life sciences group, consumer goods and retail group and telecommunications, media and technology group.

Bai Yong has unrivalled experience and knowledge of the competition law landscape within China, based on his prior experience working within MOFCOM, followed by over 10 years’ experience advising domestic and multinational corporations on antitrust and regulatory matters. He is familiar with the working practices of the various antitrust enforcement authorities in China. In addition, over the past couple of years Bai Yong has also worked in the firm's London and Brussels offices, where he gained first-hand experience of the practice of competition law in these jurisdictions. As a result, Bai Yong is one of the very few lawyers in the market able to give Chinese clients advice on global competition law issues from a Chinese perspective.

Bai Yong covers a wide range of work and industry types, including high-profile global deals such as Pfizer's US$160 billion merger with Allergan and GE's US$32 billion merger of its oil and gas business with Baker Hughes; inbound investment into China for multinational corporations such as Coca-Cola and PE funds such as CVC; outbound deals by Chinese investors, such as COFCO's acquisitions of Noble Agri and Nidera which involved approximately 30 filings across multiple jurisdictions; antitrust investigations and leniency applications for clients in the pharmaceutical, logistics and auto parts sectors; as well as compliance and regulatory work for regional and global clients.

Bai Yong frequently participates in conferences and initiatives alongside academics and officials. He is member of the translation committee of The Economic Assessment of Mergers under European Competition Law (Cambridge University Press and Law Press China, 2017). He is co-author of the chapter on antitrust and the pharmaceutical sector in China Antitrust Law Journal (2017), and a chapter on Chinese companies' navigation of outbound investment, in China's Anti-Monopoly Law – The First Five Years (Wolters Kluwer, 2013). He is also a member of the Clifford Chance team appointed by MOFCOM to advise on the rules and form for the simplified review mechanism.

Bai Yong has been recognised by Chambers Asia-Pacific as an “Associate to Watch” (2012 to 2015) and as “Up and Coming” (2016 and 2017). Feedback reflects that he "is very well known in the mainland", "can connect locally and give us that localised advice", “regularly assists on high-stakes antitrust matters”, “won plaudits for his deep knowledge of Chinese regulations and his robust MOMFCOM experience” and “is deemed key for handling high-profile transactions at a day-to-day level". In addition, Bai Yong was awarded "Competition – Rising Star" by China Law and Practice in 2014.

WWL says: Bai Yong garners praise from peers for his "deep knowledge" of competition matters.

This biography is an extract from Who's Who Legal: Competition which can be purchased from our Shop.

Who's Who Legal Competition: Future Leaders - Non Partners

Bai Yong is counsel in Clifford Chance's antitrust practice in Mainland China. Before joining the firm, he worked for the Ministry of Commerce of the People's Republic of China (MOFCOM). He is a member of the firm's healthcare and life sciences group, consumer goods and retail group and telecommunications, media and technology group.

Bai Yong has unrivalled experience and knowledge of the competition law landscape within China, based on his prior experience working within MOFCOM, followed by over 10 years’ experience advising domestic and multinational corporations on antitrust and regulatory matters. He is familiar with the working practices of the various antitrust enforcement authorities in China. In addition, over the past couple of years, Bai Yong has also worked in the firm's London and Brussels offices, where he gained first-hand experience of the practice of competition law in these jurisdictions. As a result, Bai Yong is one of the very few lawyers in the market able to give Chinese clients advice on global competition law issues from a Chinese perspective.

Bai Yong covers a wide range of work and industry types, including high profile global deals such as Pfizer's US$160 billion merger with Allergan and GE's US$32 billion merger of its oil and gas business with Baker Hughes; inbound investment into China for multinational corporations such as Coca-Cola and PE funds such as CVC; outbound deals by Chinese investors, such as COFCO's acquisitions of Noble Agri and Nidera which involved approximately 30 filings across multiple jurisdictions; antitrust investigations and leniency applications for clients in the pharmaceutical, logistics and auto parts sectors; as well as compliance and regulatory work for regional and global clients.

Bai Yong frequently participates in conferences and initiatives alongside academics and officials. He is member of the translation committee of The Economic Assessment of Mergers under European Competition Law (Cambridge University Press and Law Press China, 2017). He is co-author of the chapter on antitrust and the pharmaceutical sector in China Antitrust Law Journal (2017), and a chapter on Chinese companies' navigation of outbound investment, in China's Anti-Monopoly Law – The First Five Years (Wolters Kluwer, 2013). He is also member of the Clifford Chance team appointed by MOFCOM to advise on the rules and form for the simplified review mechanism.

Bai Yong has been recognised by Chambers Asia Pacific as an “Associate to Watch” (2012 to 2015) and as “Up and Coming” (2016 and 2017). Feedback reflects that he "is very well known in the mainland", "can connect locally and give us that localised advice", “regularly assists on high-stakes antitrust matters”, “won plaudits for his deep knowledge of Chinese regulations and his robust MOMFCOM experience” and “is deemed key for handling high-profile transactions at a day-to-day level". In addition, Bai Yong was awarded "Competition – Rising Star" by China Law and Practice in 2014.

WWL says: Bai Yong is a "very active" and "very well known" figure in the Chinese competition community.

This biography is an extract from Who's Who Legal: Competition which can be purchased from our Shop.

Follow us on LinkedIn

Practice Areas

Firms

Browse Firms

Search Firms

The Who's Who Legal 100

Awards

News & Features

Special Reports

Events

Shop

About Us

It is not possible to buy entry into any Who's Who Legal publication

Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.

Copyright © 2017 Law Business Research Ltd. All rights reserved. | http://www.lbresearch.com

87 Lancaster Road, London, W11 1QQ, UK | Tel: +44 20 7908 1180 / Fax: +44 207 229 6910

http://www.whoswholegal.com | editorial@whoswholegal.com

Law Business Research Ltd

87 Lancaster Road, London
W11 1QQ, UK